Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Docetaxel × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 7 Gastrointestinal 7 Thoracic 4 Genitourinary 4 Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 49 Carcinoma, Ovarian Epithelial 23 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 14 Endometrial Neoplasms 13 Breast Neoplasms 10 Stomach Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Prostatic Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Lung Neoplasms 6 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Peritoneal Neoplasms 5 Melanoma 5 Uterine Neoplasms 4 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Neoplasms 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Esthesioneuroblastoma, Olfactory 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Brenner Tumor 3 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2

Interventions

pembrolizumab 4 Cisplatin 4 Paclitaxel 3 lenvatinib 2 Fluorouracil 2 trastuzumab deruxtecan 1 sargramostim 1 resiquimod 1 poly ICLC 1 oregovomab 1 liposomal doxorubicin 1 fluoroazomycin arabinoside 1 fludarabine 1 catumaxomab 1 cabozantinib 1 Therapeutics 1 Therapeutic Irrigation 1 TKM-080301 1 Radiation, Ionizing 1 Radiation 1 Proctoscopy 1 Prednisone 1 Prednisolone 1 Papanicolaou Test 1 Oxaliplatin 1 Nelfinavir 1 Metformin 1 MORAb-202 1 Leucovorin 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01504256 2018-01-23

CatuNeo

AIO-Studien-gGmbH

Phase 2 Completed

Adenocarcinoma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡